A randomized trial comparing two different approaches of pacemaker selection

Europace

Volumn 9, Issue 12, 2007, Pages 1185-1190

  Kuhne M ^a   Schaer, B ^a   Kaufmann, C ^a   Moulay, N ^a   Cron, T ^a   Cueni, T ^a   Weiss, P ^a   Schindler, C ^a   Sticherling, C ^a   Osswald, S ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Atrial based pacing; Atrioventricular block; Sick sinus syndrome; Ventricular based pacing

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE; SOTALOL; WARFARIN;

AGED; ANGINA PECTORIS; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; CAUSE OF DEATH; CLINICAL TRIAL; FEMALE; FOLLOW UP; HEALTH CARE COST; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACEMAKER; HEART ATRIUM PACING; HEART FAILURE; HEART VENTRICLE PACING; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SHORT FORM 36; SICK SINUS SYNDROME; STROKE; THROMBOEMBOLISM; TREATMENT OUTCOME; BIOASSAY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECONOMICS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; ATRIOVENTRICULAR BLOCK; ENDPOINT DETERMINATION; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; PACEMAKER, ARTIFICIAL; PROSPECTIVE STUDIES; QUALITY OF LIFE; RISK FACTORS; SICK SINUS SYNDROME; TREATMENT OUTCOME;

EID: 39849107393     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eum231     Document Type: Article

References (18)

1. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002;106:2145-61.
2. Andersen HR, Nielsen JC, Thomsen PEB, Thuesen L, Vesterlund T, Pedersen AK et al. Atrioventricular conduction during long-term follow-up of patients with sick sinus syndrome. Circulation 1998;98:1315-21.
3. Andersen HR, Nielsen JC, Thomsen PE, Thuesen L, Mortensen PT, Vesterlund T et al. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997;350:1210-6.
4. Wiegand UK, Bode F, Bonnemeier H, Eberhard F, Schlei M, Peters W. Long-term complication rates in ventricular, single lead VDD, and dual chamber pacing. Pacing Clin Electrophysiol 2003;26:1961-9.
5. Wiegand UK, Potratz J, Bode F, Schreiber R, Bonnemeier H, Peters W et al. Cost-effectiveness of dual-chamber pacemaker therapy: does single lead VDD pacing reduce treatment costs of atrioventricular block. Eur Heart J 2001;22:174-80.
6. Schaer B, Weinbacher M, Zellweger M, Sticherling C, Osswald S. The clinical performance of VDD-Pacing in daily practice: long-term experience over a decade. Int J Cardiol; Published online ahead of print February 6, 2007.
7. www.pacemaker-register.de/pdf/zentralregister_ herzschrittmacher_bericht03.pdf
8. www.pacemaker.ch/de/statistik/statistik_2004.asp
9. Ware JE Jr, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36). I Conceptual framework and item selection. Med Care 1992;30:473-83.
10. Kristensen L, Nielsen JC, Pedersen AK, Mortensen PT, Andersen HR. AV block and changes in pacing mode during long-term follow-up of 399 consecutive patients with sick sinus syndrome treated with an AAI/AAIR pacemaker. Pacing Clin Electrophysiol 2001;24:358-65.
11. Kerr CR, Connolly SJ, Abdollah H, Roberts RS, Gent M, Yusuf S et al. Canadian trial of physiological pacing: effects of physiological pacing during long-term follow-up. Circulation 2004;109:357-62.
12. Connolly SJ, Kerr CR, Gent M, Roberts RS, Yusuf S, Gillis AM et al. Canadian Trial of Physiologic Pacing Investigators. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. N Engl J Med 2000;342:1385-91.
13. Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002;346:1854-62.
14. Toff WD, Camm AJ, Skehan JD et al. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. N Engl J Med 2005;353:145-55.
15. Healey JS, Toff WD, Lamas GA, Andersen HR, Thorpe KE, Ellenbogen KA et al. Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data. Circulation 2006;114:3-5.
16. Newman D, Lau C, Tang AS, Irvine J, Paquette M, Woodend K et al. Effect of pacing mode on health-related quality of life in the Canadian trial of physiologic pacing. Am Heart J 2003;145:430-7.
17. Lamas GA, Orav EJ, Stambler BS, Ellenbogen KA, Sgarbossa EB, Huang SK et al. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker selection in the elderly investigators. N Engl J Med 1998;338: 1097-104.
18. Ellenbogen KA, Wood MA. Pacemaker selection - the changing definition of physiologic pacing. N Engl J Med 2005;353:202-4.